Generative Artificial Intelligence Use, Perceptions, and Expectations Among Argentine Oncology Health Care Professionals: A Cross-Sectional Survey
JCO Global Oncology · 2026
DOI: 10.1200/go-26-00222 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift JCO Global Oncology, 2026. Verfasst von Federico Losco und 8 weiteren Autor:innen. Beteiligte Einrichtung: Asociación Argentina de Oncología Clínica (AAOC), Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Generative Artificial Intelligence, Health Personnel, Medical Oncology, Artificial Intelligence. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Purpose
To describe perceptions and use regarding generative artificial intelligence (GAI) among oncology professionals across two surveys at the Argentine Association of Clinical Oncology (AAOC) meetings (2024-2025).
Methods
Two independent cross-sectional surveys were administered on-site using an expert-consensus instrument, assessing demographics, GAI use, frequency, trust, perceived impact, training needs, and barriers. Categorical data are reported as frequencies and percentages with Wilson 95% CIs; between-year comparisons used Fisher's exact test (exploratory).
Results
A total of 268 valid responses were analyzed (2024: n = 164; 2025: n = 104); 48.1% of respondents were male, 35.4% were age 36-45 years, and 40.7% had 10-20 years of experience. GAI use in the previous month was 69.0% (95% CI, 63.3 to 74.3) overall, 61.0% (95% CI, 53.3 to 68.1) in 2024 and 80.8% (95% CI, 72.2 to 87.2) in 2025. Near-daily use rose from 12.2% (95% CI, 8.0 to 18.1) to 33.7% (95% CI, 25.3 to 43.2) and was more frequent among younger participants ( P = .048; P = .009). Main applications include administrative tasks (54.9%), scientific retrieval (41.8%), clinical consultation (15.3%), and patient information (7.1%). Most (79.1%, 95% CI, 73.8 to 83.5) had no formal GAI training; 92.9% (95% CI, 89.2 to 95.4) considered it necessary and 82.5% (95% CI, 77.5 to 86.5) believed GAI can improve cancer care. Trust in AI recommendations was higher in 2025 (67.3%, 95% CI, 57.8 to 75.6) than in 2024 (51.8%, 95% CI, 44.2 to 59.3). Privacy concerns (87.3%, 95% CI, 82.8 to 90.8), legal liability (70.1%), and support for regulation (84.0%, 95% CI, 79.1 to 87.9) were widespread.
Conclusion
GAI use was high and increasing, occurring without institutional support or formal training. These findings support educational program development and context-appropriate guidance for responsible adoption. To our knowledge, this is the first study characterizing GAI perception and use among oncology professionals in Argentina.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Asociación Argentina de Oncología Clínica (AAOC), Buenos Aires, Argentina.
- Hospital Alemán de Buenos Aires, Buenos Aires, Argentina.
- Instituto Universitario CEMIC, Buenos Aires, Argentina.
- Hospital Universitario Austral, Buenos Aires, Argentina.
- Instituto Alexander Fleming, Buenos Aires, Argentina.
- Hospital de Alta Complejidad, Formosa, Argentina.
ORCID-Profile: Federico Losco, Andrea Marchioni, Diego H Enrico, Pablo E Companys, Martin Angel
Zitieren
APA
Losco, F., Marchioni, A., Diaz-Canton, E. A., Barros, J. M., Enrico, D. H., Companys, P. E., Angel, M., Oberti, R., & Picón, C. R. (2026). Generative Artificial Intelligence Use, Perceptions, and Expectations Among Argentine Oncology Health Care Professionals: A Cross-Sectional Survey. JCO Global Oncology. https://doi.org/10.1200/go-26-00222
Vancouver
Losco F, Marchioni A, Diaz-Canton EA, Barros JM, Enrico DH, Companys PE, et al. Generative Artificial Intelligence Use, Perceptions, and Expectations Among Argentine Oncology Health Care Professionals: A Cross-Sectional Survey. JCO Global Oncology. 2026. doi:10.1200/go-26-00222
BibTeX
@article{Losco2026,
author = {Losco, Federico and Marchioni, Andrea and Diaz-Canton, Enrique A and Barros, José M and Enrico, Diego H and Companys, Pablo E and Angel, Martin and Oberti, Román and Picón, Carlos R},
title = {Generative Artificial Intelligence Use, Perceptions, and Expectations Among Argentine Oncology Health Care Professionals: A Cross-Sectional Survey},
journal = {JCO Global Oncology},
year = {2026},
doi = {10.1200/go-26-00222}
}
EUVIMED